CPCR members (Fred Barrett, Jessica Dyal, Tess Richardson) attended the kickoff meeting for Reunion Neuroscience’s REKINDLE trial, which will test RE-104—a shorter-acting psilocybin-like compound—for adjustment disorder. Stay tuned for recruitment updates!